Schizophrenia Treatment Guidelines

Introduction to Schizophrenia Symptoms

The American Psychiatric Association notes that positive symptoms in schizophrenia include hallucinations, delusions, disorganized thoughts and behavior, and agitation, while negative symptoms comprise five core domains: avolition, anhedonia, asociality, blunted affect, and alogia 1

Up to 90% of patients experiencing first-episode psychosis present with at least one negative symptom, and these persist in 35-70% of patients after treatment, according to the National Institute of Mental Health 1
Negative symptoms carry substantially greater functional burden than positive symptoms, affecting approximately 40% of people with schizophrenia prominently, and are associated with low remission rates, impaired academic and occupational performance, and poor social functioning 1

The American College of Neuropsychopharmacology recommends starting with dopamine D2 receptor antagonist or partial agonist antipsychotic monotherapy, which effectively reduces positive symptoms in approximately 70-80% of patients 2
For predominant negative symptoms with controlled positive symptoms, the European Psychiatric Association suggests switching to cariprazine or aripiprazole, as aripiprazole shows standardized mean difference of -0.41 for negative symptom improvement 3, 4
Cognitive remediation therapy shows robust effect sizes and should be offered with 1B evidence rating, according to the National Institute of Mental Health 3, 2

The World Health Organization recommends assessing symptom response at 6-8 weeks using structured assessment tools such as the Positive and Negative Syndrome Scale (PANSS) or Scale for Assessing Negative Symptoms (SANS) 4

The American Academy of Child and Adolescent Psychiatry recommends offering cognitive remediation therapy with 1B evidence rating, as it shows robust effect sizes for negative symptoms including anhedonia, in patients with schizophrenia 5
The American Academy of Child and Adolescent Psychiatry suggests implementing psychoeducational interventions, social skills training, and cognitive-behavioral strategies as essential adjuncts to medication, particularly focusing on the disabling negative symptoms including anhedonia, in patients with schizophrenia 5
Family treatment and group therapies developed according to the patient's developmental level improve outcomes when combined with pharmacotherapy, in patients with schizophrenia 5